-+ 0.00%
-+ 0.00%
-+ 0.00%
Telix Participates in UBS Global Biopharma Conference
Share
Listen to the news
Telix Participates in UBS Global Biopharma Conference
  • Telix Pharmaceuticals will participate in the UBS Global Biopharma Conference in London on Nov. 17, 2026.
  • Group CEO Christian Behrenbruch and Therapeutics CEO Richard Valeix will join a fireside chat at 9:20 a.m. GMT, webcast live.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telix Pharmaceuticals Ltd. published the original content used to generate this news brief on November 11, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending